Compare DAIO & CCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DAIO | CCEL |
|---|---|---|
| Founded | 1969 | 1989 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Electrical Products | Managed Health Care |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 29.1M | 32.7M |
| IPO Year | 1995 | 2022 |
| Metric | DAIO | CCEL |
|---|---|---|
| Price | $2.86 | $3.38 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 1 | 1 |
| Target Price | ★ $5.22 | N/A |
| AVG Volume (30 Days) | ★ 21.1K | 12.4K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | ★ 4.41% |
| EPS Growth | N/A | ★ 104.39 |
| EPS | N/A | ★ 0.17 |
| Revenue | $21,769,000.00 | ★ $25,384,279.00 |
| Revenue This Year | $7.40 | $0.30 |
| Revenue Next Year | $2.10 | N/A |
| P/E Ratio | ★ N/A | $20.03 |
| Revenue Growth | N/A | ★ 9.76 |
| 52 Week Low | $1.90 | $3.10 |
| 52 Week High | $3.49 | $8.00 |
| Indicator | DAIO | CCEL |
|---|---|---|
| Relative Strength Index (RSI) | 40.07 | 48.43 |
| Support Level | $2.56 | $3.33 |
| Resistance Level | $2.90 | $3.57 |
| Average True Range (ATR) | 0.15 | 0.16 |
| MACD | -0.02 | 0.01 |
| Stochastic Oscillator | 18.04 | 63.50 |
Data I/O Corp is a provider of programming, security deployment, security provisioning, and associated Intellectual Property protection and management solutions used in electronics manufacturing with flash memory, microcontrollers, and flash memory-based intelligent devices as well as secure element devices, authentication devices, and secure microcontrollers. It is engaged in focused on the design, manufacturing and sale of programming systems used by designers and manufacturers of electronic products. It has its geographic presence in the United States, Europe, and Asia and others. The company derives the majority of its revenue from Asia and others.
Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of PrepaCyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The Public cord blood banking segment consists of cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The company generates maximum revenue from Cellular processing and Cryogenic storage and it derives revenue from processing and testing fees and Storage segment.